Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169175
What this trial is testing
A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS
Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
SineuGene Therapeutics Co., Ltd. 21
Showing 20 of 0 results